Aflibercept in wet AMD: specific role and optimal use
F Semeraro,1 F Morescalchi,1 S Duse,1 F Parmeggiani,2 E Gambicorti,1 C Costagliola31Department of Medical and Surgical Specialties, Radiological Specialties and Public Health, Ophthalmology Clinic, University of Brescia, Brescia, Italy; 2Department of Ophthalmology, University of Ferrara, Ferrara, I...
Saved in:
Main Authors: | Semeraro F (Author), Morescalchi F (Author), Duse S (Author), Parmeggiani F (Author), Gambicorti E (Author), Costagliola C (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2013-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proliferative Vitreoretinopathy after Eye Injuries: An Overexpression of Growth Factors and Cytokines Leading to a Retinal Keloid
by: Francesco Morescalchi, et al.
Published: (2013) -
Management of wet AMD in an elderly patient - case report
by: Katarzyna Nowakowska, et al.
Published: (2021) -
Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
by: Nicola Ferrante, et al.
Published: (2022) -
The role of aflibercept in the management of diabetic macular edema
by: Chang AA, et al.
Published: (2015) -
Glioma-associated radiation retinopathy treated successfully with aflibercept
by: Karagiannis D, et al.
Published: (2019)